» Articles » PMID: 32602008

Long Non-coding RNA MALAT1/microRNA-143/VEGFA Signal Axis Modulates Vascular Endothelial Injury-Induced Intracranial Aneurysm

Overview
Publisher Springer
Specialty Biotechnology
Date 2020 Jul 1
PMID 32602008
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The roles of some long non-coding RNAs (lncRNAs) in intracranial aneurysm (IA) have been investigated in many studies. The aim of this study is to elucidate the mechanism of lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1)/microRNA-143 (miR-143)/vascular endothelial growth factor-A (VEGFA) signal axis in vascular endothelial injury-induced IA. MALAT1, miR-143, and VEGFA expression in IA tissues and normal arterial tissues were detected. Matrix metalloproteinase 9 (MMP-9) in tissues, von Willebrand factor (vWF) in serum and tissues, and endothelin-1 (ET-1) in serum were detected. The modeled IA rats were injected with silenced or overexpressed MALAT1 for detecting vascular endothelial injury. Vascular endothelial cells from patients with IA were abstracted and transfected with silenced or overexpressed MALAT1 to verify the impacts of MALAT1 on cell viability and apoptosis. The connections among MALAT1, miR-143, and VEGFA were verified by online prediction, luciferase activity, and RNA-pull down assays. Overexpression of MALAT1 and VEGFA and poor expression of miR-143 were found in IA tissues. Downregulation of MALAT1 inhibited blood pressure, the expression of ET-1, vWF, and MMP-9, as well as the apoptotic index of vascular endothelial cells of rats with IA. Downregulated MALAT1 inhibited apoptosis and promoted viability of vascular endothelial cells in IA. MALAT1 bound to miR-143 and miR-143 targeted VEGFA. This study suggests that MALAT1 elevates VEGFA expression through competitive binding to miR-143, thereby boosting apoptosis and attenuating viability of vascular endothelial cells in IA.

Citing Articles

Intracranial aneurysm circulating exosome-derived LncRNA ATP1A1-AS1 promotes smooth muscle cells phenotype switching and apoptosis.

Wang C, Li H, Zhou H, Xu Y, Li S, Zhu M Aging (Albany NY). 2024; 16(9):8320-8335.

PMID: 38728254 PMC: 11132007. DOI: 10.18632/aging.205821.


Aberrant expression and regulatory role of histone deacetylase 9 in vascular endothelial cell injury in intracranial aneurysm.

Sun J, Zhang L, Cheng Q, Wu Y Biomol Biomed. 2023; 24(1):61-72.

PMID: 37573538 PMC: 10787617. DOI: 10.17305/bb.2023.9364.


Identification of immune-related molecular markers in intracranial aneurysm (IA) based on machine learning and cytoscape-cytohubba plug-in.

Ma Z, Zhong P, Yue P, Sun Z BMC Genom Data. 2023; 24(1):20.

PMID: 37041519 PMC: 10088219. DOI: 10.1186/s12863-023-01121-w.


Nomogram model for predicting oculomotor nerve palsy in patients with intracranial aneurysm.

Cui Y, Wang B, Jiang B, Zhao S Int J Ophthalmol. 2022; 15(8):1316-1321.

PMID: 36017047 PMC: 9358192. DOI: 10.18240/ijo.2022.08.14.


Transcriptome-Based Dissection of Intracranial Aneurysms Unveils an "Immuno-Thermal" Microenvironment and Defines a Pathological Feature-Derived Gene Signature for Risk Estimation.

Lu T, Liu Z, Guo D, Ma C, Duan L, He Y Front Immunol. 2022; 13:878195.

PMID: 35711443 PMC: 9194475. DOI: 10.3389/fimmu.2022.878195.